Childhood Spinal Cord Neoplasm Completed Phase 2 / 3 Trials for Temozolomide (DB00853)
Indication | Status | Phase |
---|---|---|
DBCOND0030212 (Childhood Spinal Cord Neoplasm) | Completed | 2 / 3 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01236560 | Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma | Treatment |